CryoCell International Net Income
| CCEL Stock | USD 3.43 0.06 1.78% |
As of the 14th of February 2026, CryoCell International shows the Risk Adjusted Performance of (0.07), mean deviation of 2.14, and Standard Deviation of 3.08. CryoCell International technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CryoCell International market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if CryoCell International is priced correctly, providing market reflects its regular price of 3.43 per share. Given that CryoCell International has information ratio of (0.11), we suggest you to validate CryoCell International's prevailing market performance to make sure the company can sustain itself at a future point.
CryoCell International Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.1504 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 462.4 K | 485.5 K | |
| Net Income Applicable To Common Shares | 3.2 M | 2.1 M | |
| Net Income From Continuing Ops | 361.9 K | 698.5 K | |
| Net Income Per Share | 0.04 | 0.05 | |
| Net Income Per E B T | 0.14 | 0.16 |
CryoCell | Net Income | Build AI portfolio with CryoCell Stock |
Historical Net Income data for CryoCell International serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether CryoCell International represents a compelling investment opportunity.
Latest CryoCell International's Net Income Growth Pattern
Below is the plot of the Net Income of CryoCell International over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in CryoCell International financial statement analysis. It represents the amount of money remaining after all of CryoCell International operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is CryoCell International's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CryoCell International's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 402.1 K | 10 Years Trend |
|
Net Income |
| Timeline |
CryoCell Net Income Regression Statistics
| Arithmetic Mean | 359,951 | |
| Geometric Mean | 1,193,353 | |
| Coefficient Of Variation | 1,062 | |
| Mean Deviation | 2,326,833 | |
| Median | 485,530 | |
| Standard Deviation | 3,821,415 | |
| Sample Variance | 14.6T | |
| Range | 17.6M | |
| R-Value | (0.02) | |
| Mean Square Error | 15.6T | |
| R-Squared | 0.0004 | |
| Significance | 0.94 | |
| Slope | (15,315) | |
| Total Sum of Squares | 233.7T |
CryoCell Net Income History
Other Fundumenentals of CryoCell International
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
CryoCell International Net Income component correlations
CryoCell Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for CryoCell International is extremely important. It helps to project a fair market value of CryoCell Stock properly, considering its historical fundamentals such as Net Income. Since CryoCell International's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CryoCell International's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CryoCell International's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. Projected growth potential of CryoCell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CryoCell International assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.31) | Dividend Share 0.65 | Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth (0.03) |
Investors evaluate CryoCell International using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating CryoCell International's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause CryoCell International's market price to deviate significantly from intrinsic value.
It's important to distinguish between CryoCell International's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CryoCell International should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, CryoCell International's market price signifies the transaction level at which participants voluntarily complete trades.
CryoCell International 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CryoCell International's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CryoCell International.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in CryoCell International on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding CryoCell International or generate 0.0% return on investment in CryoCell International over 90 days. CryoCell International is related to or competes with BioAffinity Technologies, Artelo Biosciences, Revelation Biosciences, WORK Medical, GT Biopharma, Psyence Biomedical, and Protagenic Therapeutics. Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the coll... More
CryoCell International Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CryoCell International's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CryoCell International upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 16.21 | |||
| Value At Risk | (4.94) | |||
| Potential Upside | 4.71 |
CryoCell International Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CryoCell International's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CryoCell International's standard deviation. In reality, there are many statistical measures that can use CryoCell International historical prices to predict the future CryoCell International's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (2.10) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CryoCell International's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CryoCell International February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (2.09) | |||
| Mean Deviation | 2.14 | |||
| Coefficient Of Variation | (1,110) | |||
| Standard Deviation | 3.08 | |||
| Variance | 9.46 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (2.10) | |||
| Maximum Drawdown | 16.21 | |||
| Value At Risk | (4.94) | |||
| Potential Upside | 4.71 | |||
| Skewness | (0.48) | |||
| Kurtosis | 2.31 |
CryoCell International Backtested Returns
CryoCell International secures Sharpe Ratio (or Efficiency) of -0.0718, which signifies that the company had a -0.0718 % return per unit of risk over the last 3 months. CryoCell International exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CryoCell International's Risk Adjusted Performance of (0.07), mean deviation of 2.14, and Standard Deviation of 3.08 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CryoCell International's returns are expected to increase less than the market. However, during the bear market, the loss of holding CryoCell International is expected to be smaller as well. At this point, CryoCell International has a negative expected return of -0.22%. Please make sure to confirm CryoCell International's value at risk, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if CryoCell International performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.57 |
Modest predictability
CryoCell International has modest predictability. Overlapping area represents the amount of predictability between CryoCell International time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CryoCell International price movement. The serial correlation of 0.57 indicates that roughly 57.0% of current CryoCell International price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.57 | |
| Spearman Rank Test | 0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
CryoCell Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, CryoCell International reported net income of 402.1 K. This is 99.88% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 99.93% higher than that of the company.
CryoCell Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CryoCell International's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CryoCell International could also be used in its relative valuation, which is a method of valuing CryoCell International by comparing valuation metrics of similar companies.CryoCell International is currently under evaluation in net income category among its peers.
CryoCell International ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CryoCell International's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CryoCell International's managers, analysts, and investors.Environmental | Governance | Social |
CryoCell International Institutional Holders
Institutional Holdings refers to the ownership stake in CryoCell International that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of CryoCell International's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing CryoCell International's value.| Shares | Jones Financial Companies Lllp | 2025-06-30 | 1.3 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 601 | Tower Research Capital Llc | 2025-06-30 | 464 | Compass Financial Services Inc | 2025-06-30 | 200 | Signaturefd, Llc | 2025-06-30 | 100.0 | Ubs Group Ag | 2025-06-30 | 100.0 | Bank Of America Corp | 2025-06-30 | 37.0 | Jpmorgan Chase & Co | 2025-06-30 | 11.0 | Sbi Securities Co Ltd | 2025-06-30 | 2.0 | Hamilton Lane Advisors Llc | 2025-06-30 | 409.7 K | Sfi Advisors, Llc | 2025-06-30 | 165.3 K |
CryoCell Fundamentals
| Return On Equity | 1.29 | ||||
| Return On Asset | 0.0429 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 36.52 M | ||||
| Shares Outstanding | 8.06 M | ||||
| Shares Owned By Insiders | 41.97 % | ||||
| Shares Owned By Institutions | 12.14 % | ||||
| Number Of Shares Shorted | 9.45 K | ||||
| Price To Earning | 10.76 X | ||||
| Price To Book | 9.72 X | ||||
| Price To Sales | 0.87 X | ||||
| Revenue | 31.99 M | ||||
| Gross Profit | 24.47 M | ||||
| EBITDA | 1.42 M | ||||
| Net Income | 402.1 K | ||||
| Cash And Equivalents | 2.96 M | ||||
| Cash Per Share | 0.35 X | ||||
| Total Debt | 12.93 M | ||||
| Debt To Equity | 0.26 % | ||||
| Current Ratio | 0.47 X | ||||
| Book Value Per Share | (1.84) X | ||||
| Cash Flow From Operations | 6.01 M | ||||
| Short Ratio | 0.46 X | ||||
| Earnings Per Share | (0.06) X | ||||
| Target Price | 8.5 | ||||
| Number Of Employees | 82 | ||||
| Beta | 0.65 | ||||
| Market Capitalization | 27.61 M | ||||
| Total Asset | 64.68 M | ||||
| Retained Earnings | (32.78 M) | ||||
| Working Capital | (9.04 M) | ||||
| Current Asset | 6.08 M | ||||
| Current Liabilities | 2.82 M | ||||
| Annual Yield | 0.18 % | ||||
| Net Asset | 64.68 M | ||||
| Last Dividend Paid | 0.65 |
About CryoCell International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CryoCell International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CryoCell International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CryoCell International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. Projected growth potential of CryoCell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CryoCell International assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.31) | Dividend Share 0.65 | Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth (0.03) |
Investors evaluate CryoCell International using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating CryoCell International's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause CryoCell International's market price to deviate significantly from intrinsic value.
It's important to distinguish between CryoCell International's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CryoCell International should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, CryoCell International's market price signifies the transaction level at which participants voluntarily complete trades.